METHOD FOR PREDICTING THE PRESENCE OF SARCOMA IN WOMEN WITH PROLIFERATING UTERINE MYOMA Russian patent published in 2019 - IPC A61B5/00 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, gynecology, intended to predict the development of sarcoma in women with proliferating uterine myoma. Includes anamnestic data collection. Doppler ultrasound and color doppler mapping are carried out. Sugar content is determined by the glycosidase photometric method. Prognostic markers are determined: age of 50 years or more, presence of external endometriosis, postmenopausal hemorrhage, history of uterine fibroids, diabetes mellitus. Prognostic screening points (PSP) are set for each factor. In the system, age with a marker age 50 years and older, the PSP is set equal to (+3), less than 50 years – 0. In the system, the presence of external genital endometriosis with a marker there is external endometriosis, the PSP is set to (+3), if no – 0. In the system, postmenopausal hemorrhage, with a marker, the PSP is set equal to (+4), if no – 0. In the system, the presence of proliferating uterine fibroids, with a marker the PSP is set equal to (+6), if no – 0. In the system, the presence of diabetes mellitus, with a marker the PSP is set to SAT (+3), if no – 0. Obtained screening points are summarized. If the value of the points sum is (+7) and more the presence of uterine sarcoma is diagnosed. If the value of the points amount is less than (+7), the proliferating uterus myoma is diagnosed.

EFFECT: method provides the accuracy of predicting the presence of sarcoma in women with proliferating uterine myoma and allows for differential diagnosis to assign the correct treatment.

1 cl, 2 tbl, 2 ex